Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Date:11/6/2009

ontains forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties, including activities, events or developments that we expect, believe or anticipate will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including our ability to raise additional funds or enter strategic alliances, advance development of our potential products and complete research and development, including pre-clinical and clinical studies, the continuation of arrangements with our product development partners and customers, competition, government regulation and approvals, and general economic conditions. For example, we may not obtain regulatory approval for our products, which would materially impair our ability to generate revenue. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the Securities and Exchange Commission. Such filings are available on our website or at www.sec.gov. You are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances.

    Contacts:
    Investor Relations
    info@scolr.com
    SCOLR Pharma, Inc.
    425-368-1050 ext 1080


                                SCOLR Pharma, Inc.

                             CONDENSED BALANCE SHEETS
                                   (Unaudited)

                                              September 30
'/>"/>
SOURCE  SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 

Related medicine technology :

1. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
4. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
5. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
6. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
7. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
8. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
9. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
10. Northern Light Adds 4,000 Bio-Pharma, Health Sciences and General Business News and Journal Sources from EBSCO Publishing
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/--Hologic,Inc.(Hologicor...acturerandsupplierofpremiumdiagnostics,medicalimag...healthcareneedsofwomen,isusingtheannualmeetingofth...kPlaceinChicago,November29throughDecember3,2009toh...nosticmammographyworkstationsoftware. ,, TheHol...
(Date:11/25/2009)....25/PRNewswire-FirstCall/--ERT(Nasdaq: ERES ),anno...sidentandCEO,andKeithSchneck,theCompany,sExecutive...AnnualPiperJaffrayHealthCareConferenceat1:30PMESTo...stedpartiesmayaccessthepresentationbyvisitingtheCo...ebcastmayalsobeaccessedat http://www.corporate-ir....
(Date:11/25/2009).../PRNewswire/--BioTrendsResearchGroup,Inc.releasedW...efirstinamulti-phasesyndicatedmarketresearchprojec...,fromproductlaunchthroughthefirstsixmonthsofavaila...rmationfrom75uniqueDermatologistsandqualitativeinf...eofStelara,obstaclestouse,typicalpatienttypes,prod...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 1Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 2Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 3New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 1New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 2New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 3Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange 28TM 29 61028 1Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange 28TM 29 61028 2
...euticals, Inc.,(Nasdaq: SGXP ) today announced th..., with the first patient being treated on January ...uate the safety, tolerability and,pharmacokinetic ...bioavailable, small molecule inhibitor of the cMET...trials are open-label, dose escalation studies of,...
...on (FDA) has accepted for filing the New, Drug App...iracetam) in the, adjunctive treatment of partia..., Jan. 16 UCB announced today that the New Drug,A...etiracetam) extended-,release tablets in the adjun...s with epilepsy has been accepted for filing by th...
Other Medicine Technology:SGX Initiates Phase I Trials for SGX523 2SGX Initiates Phase I Trials for SGX523 3Keppra XR(TM) Extended-Release Tablets Filed with the FDA 2Keppra XR(TM) Extended-Release Tablets Filed with the FDA 3Keppra XR(TM) Extended-Release Tablets Filed with the FDA 4
(Date:11/26/2009)... Research Triangle Dental (RTDental), a le...ina, today announced the expansion of its services...ist, Dr. Doug Macmillan. , ...l is pleased to announce that Dr. Doug Macmillan, ...eted an additional advanced training seminar. RTD...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free ... Yaz and Yasmin birth control pills who have suffe...sm, Stroke, Heart Attack or other related cardiac ... call toll free at 1-800-856-6405 or go to the fir... fill out an online case evaluation form. , ...
(Date:11/25/2009)...Y,Mo.,Nov.25/PRNewswire/--TheBartleHallConventionC...lcliniconDec.9-10,whenKansasCityhoststhelatestinas... "Thisfreecliniceventhasthepotentialtobethebiggest...oneandbeheldonweekdaysinsteadofoveraweekend,"Sheri...nicandpresidentoftheNationalAssociationofFreeClini...
(Date:11/25/2009)...dCALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,...)coilsandsoftwareandCalgaryScientificInc.,aleading...cedawebversionofAegis(TM)Breast4DAdvancedVisualiza...rsttrulyzero-footprintWebclientbasedmedicalimaging...platformallowsforzero-footprintaccess-requiringnos...
(Date:11/25/2009)...,Calif.,Nov.25/PRNewswire/--Thanksgivingmealswillb...egreaterLongBeachareathankstoFaithInAction/Volunte...ome(IAH),adivisionofSCANHealthPlan.Formorethan17ye...erstodeliverwarmThanksgivingmealstoseniorsinneedin...elesandsurroundingcities. ,, "Ourwarmholidaymea...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...nds 30% risk reduction when felines are in the hom...- Whether it,s a frisky kitten or a tubby tabby, a...lmost a third, a new study suggests. , The finding...feel left out: Although the study found no such be...
...y determines similarities, differences in DNA, stu...y News) -- In the largest such examination of hum...al team of geneticists has used clues in DNA to tr...ord University, looked at more than 650,000 varian...
...GTON, Ky. (Feb. 21, 2008) − It,s the leading...s--a disease characterized by the thickening of ar... pipe. Preventing and reversing this disease is st...uffer its devastating effects worldwide. , So note...
...GH, Feb. 21 Mylan Inc. (NYSE: MYL ),announced to... call and,live webcast for the quarter and nine mo...008, to 5 p.m. ET from 10:30 a.m. as previously,an...t,days, will be available at 888-203-1112 or 719-4...
...D, Ill., Feb. 21 American Imaging Management,(AIM...E: WLP ), and a,leading radiology benefit managem...s representing over 20 million consumers, has intr...aphy,(CT) scans and positron emission tomography (...
...l, myths, complacency, lack of political will and ...the fight against HIV and AIDS. And with no cure o...ramount importance, according to Professor Lars Ka...llings says that: Trust in modern science is so gr...
Other Medicine News:Health News:Cats Help Shield Owners From Heart Attack 2Health News:Cats Help Shield Owners From Heart Attack 3Health News:Global Analysis of Human DNA Tracks Migration, Identity 2Health News:Global Analysis of Human DNA Tracks Migration, Identity 3Health News:Global Analysis of Human DNA Tracks Migration, Identity 4Health News:American Imaging Management Launches Patient Safety Program to Increase Awareness of Radiation Dose Associated with Advanced Imaging Procedures 2Health News:American Imaging Management Launches Patient Safety Program to Increase Awareness of Radiation Dose Associated with Advanced Imaging Procedures 3Health News:Lack of political will and the subordination of women are major barriers to tackling AIDS 2Health News:Lack of political will and the subordination of women are major barriers to tackling AIDS 3Health News:Lack of political will and the subordination of women are major barriers to tackling AIDS 4
3.5V Diagnostic Otoscope with Insufflator Bulb
3.5V MacroViewOtoscope/Throat Illuminator
Novus Spectra Photocoagulator
Fison Indirect Ophthalmoscope
Medicine Products: